Core B - Clinical Core
Core B - Clinical Core
批准号:
9251141
负责人:
Teresa Gomez-Isla
金额:
$83.29万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Alzheimer&aposs DiseaseAnatomyAreaAssessment toolAutopsyAwarenessBehavior assessmentBehavioralBiologicalBloodBrain DiseasesClinicalClinical DataClinical ResearchCognitionCognitiveCollaborationsCommunitiesDataData CollectionData SetDementiaDetectionDevelopmentDiseaseEarly DiagnosisEarly InterventionEarly intervention trialsElderlyEligibility DeterminationEnsureEnvironmentEtiologyEvaluationFrontotemporal DementiaFuture GenerationsGeneral HospitalsGenetic MarkersGoalsHospitalsIndividualInternationalLanguageLewy Body DementiaLewy Body DiseaseLinkLiquid substanceLongitudinal cohortMassachusettsMeasuresMemory DisordersMinority GroupsMissionMolecularMulticenter StudiesParkinson&aposs DementiaParticipantPathologicPatientsPhasePreventionProtocols documentationRecruitment ActivityRegistriesResearchResearch PersonnelResearch Project GrantsResearch SupportRiskRoleSamplingScanningScientistStructureTimeTrainingVascular Cognitive ImpairmentWomanWorkcareer developmentcognitive functioncognitive testingcohortethnic diversityfollow-upimprovedindexinginnovationleadership developmentmenmild cognitive impairmentminority subjectsneuroimagingneuropathologynext generationnoveloutreachpre-clinicalpreventprogramsracial and ethnicresearch studysocioeconomicssuccesssystematic reviewunderserved minorityvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CLINICAL CORE PROJECT SUMMARY/ABSTRACT
The mission of the Clinical Core parallels that of the MADRC as a whole: To support research into the causes,
mechanisms and treatment of AD and related dementias, with the eventual goal of curing and even preventing
these disorders. When first established in 1984, much of our work centered on AD, beginning with AD dementia
and expanding to Mild Cognitive Impairment (MCI). The focus broadened over the past 5 years as investigators
in the Core developed specific research programs in vascular cognitive impairment, Parkinson disease
dementia/dementia with Lewy bodies, and frontotemporal dementia. We now expand our Core's focus further to
emphasize the behavioral and biological features of normal elders at risk for dementia and those with subjective
cognitive concerns. In order to facilitate clinical research in these areas, we have established and maintain a
Longitudinal Cohort (LC) of men and women from diverse ethnic and racial backgrounds spanning a full range
of cognitive function from normal to subjective complaints to MCI to dementia. Comprehensive and systematic
examination of this cohort is central to the Clinical Core mission. From this well-characterized and longitudinally
followed cohort, we provide timely and accurate data submission to NACC; subjects for national multi-center
studies such as ADNI, DIAN and ADCS trials; and biological samples for genetic and biomarker research. The
LC also fuels our Center's local research studies: we will continue to support the more than 40 studies that rely
on our evaluations and our subjects, their data and/or their biologic fluids for success, including Projects 1 and 2
in this renewal application. A special emphasis of our Core, in line with our Center's theme of understanding and
recognizing the earliest phase of disease, is the development of novel assessment tools that can be used in our
and others' studies in this area. We will also work on referring subjects to the new Neuroimaging Core, on
supporting the new Recruitment Registry in the Outreach Core, and on coordinating with the Neuropathology
Core to facilitate smooth autopsy protocols. The Core will join with the Outreach Core in raising awareness
about AD and dementias, and assist in increasing the number of minority subjects who have access to LC and
research projects. A final goal of the Core is help train the next generation of investigators, and we will continue
to attract promising clinician-scientists and provide a stimulating environment for their career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
-
批准号:10378614
-
项目类别:
-
资助金额:$80.86万
-
财政年份:2019
-
负责人:Teresa Gomez-Isla
-
依托单位:
Clinical Core
-
批准号:10620669
-
项目类别:
-
资助金额:$80.86万
-
财政年份:2019
-
负责人:Teresa Gomez-Isla
-
依托单位:
Core B - Clinical Core
-
批准号:8676351
-
项目类别:
-
资助金额:$78.18万
-
财政年份:2014
-
负责人:Teresa Gomez-Isla
-
依托单位:
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience
-
批准号:8676357
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2014
-
负责人:Teresa Gomez-Isla
-
依托单位:
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology
-
批准号:8878973
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2013
-
负责人:Teresa Gomez-Isla
-
依托单位:
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology
-
批准号:8579025
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2013
-
负责人:Teresa Gomez-Isla
-
依托单位:
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology
-
批准号:8728099
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2013
-
负责人:Teresa Gomez-Isla
-
依托单位:
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology
-
批准号:9291396
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2013
-
负责人:Teresa Gomez-Isla
-
依托单位:
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience
-
批准号:8829096
-
项目类别:
-
资助金额:$21.1万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience
-
批准号:9052100
-
项目类别:
-
资助金额:$21.75万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
Core B - Clinical Core
-
批准号:8829090
-
项目类别:
-
资助金额:$75.83万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
Clinical Core
-
批准号:9914207
-
项目类别:
-
资助金额:$85.26万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
Core B - Clinical Core
-
批准号:9462720
-
项目类别:
-
资助金额:$78.21万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
Project 2: Neuropathology of Amyloid and Tau
-
批准号:9097508
-
项目类别:
-
资助金额:$26.98万
-
财政年份:--
-
负责人:Teresa Gomez-Isla
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: